SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-106802
Filing Date
2022-04-15
Accepted
2022-04-15 16:11:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d339918d424b5.htm 424B5 198145
2 GRAPHIC g339918g0414042400414.jpg GRAPHIC 7928
3 GRAPHIC g339918g81k15.jpg GRAPHIC 55398
  Complete submission text file 0001193125-22-106802.txt   282214
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-262711 | Film No.: 22830164
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences